pubmed-article:18483370 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18483370 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18483370 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:18483370 | lifeskim:mentions | umls-concept:C0376545 | lld:lifeskim |
pubmed-article:18483370 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
pubmed-article:18483370 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:18483370 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
pubmed-article:18483370 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:18483370 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:18483370 | pubmed:dateCreated | 2008-5-16 | lld:pubmed |
pubmed-article:18483370 | pubmed:abstractText | CT-011 is a humanized IgG1 monoclonal antibody that modulates the immune response through interaction with PD-1, a protein belonging to the B7 receptor family present on lymphocytes. The objectives of this phase I study were to assess the dose-limiting toxicities, to determine the maximum tolerated dose, and to study the pharmacokinetics of CT-011 administered once to patients with advanced hematologic malignancies. | lld:pubmed |
pubmed-article:18483370 | pubmed:language | eng | lld:pubmed |
pubmed-article:18483370 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483370 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18483370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483370 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18483370 | pubmed:month | May | lld:pubmed |
pubmed-article:18483370 | pubmed:issn | 1078-0432 | lld:pubmed |
pubmed-article:18483370 | pubmed:author | pubmed-author:NaglerArnonA | lld:pubmed |
pubmed-article:18483370 | pubmed:author | pubmed-author:ShimoniAvicha... | lld:pubmed |
pubmed-article:18483370 | pubmed:author | pubmed-author:Rotem-Yehudar... | lld:pubmed |
pubmed-article:18483370 | pubmed:author | pubmed-author:KnellerAbraha... | lld:pubmed |
pubmed-article:18483370 | pubmed:author | pubmed-author:BergerRaananR | lld:pubmed |
pubmed-article:18483370 | pubmed:author | pubmed-author:Koren-Michowi... | lld:pubmed |
pubmed-article:18483370 | pubmed:author | pubmed-author:LeibaMeravM | lld:pubmed |
pubmed-article:18483370 | pubmed:author | pubmed-author:SlamaGideonG | lld:pubmed |
pubmed-article:18483370 | pubmed:author | pubmed-author:LandesShimonS | lld:pubmed |
pubmed-article:18483370 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18483370 | pubmed:day | 15 | lld:pubmed |
pubmed-article:18483370 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:18483370 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18483370 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18483370 | pubmed:pagination | 3044-51 | lld:pubmed |
pubmed-article:18483370 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:meshHeading | pubmed-meshheading:18483370... | lld:pubmed |
pubmed-article:18483370 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18483370 | pubmed:articleTitle | Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. | lld:pubmed |
pubmed-article:18483370 | pubmed:affiliation | Institute of Oncology and Radiotherapy, Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel. | lld:pubmed |
pubmed-article:18483370 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18483370 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18483370 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18483370 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18483370 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18483370 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18483370 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18483370 | lld:pubmed |